StockStory.org on MSN
GoodRx (GDRX): Buy, sell, or hold post Q3 earnings?
GoodRx’s stock price has taken a beating over the past six months, shedding 56.5% of its value and falling to $2.23 per share ...
TrumpRx launched with more than 40 medications at discounted prices after negotiations with more than a dozen drug companies.
TrumpRx taps GoodRx discounted drug pricing to offer patients up to 85% savings on Pfizer and other brand-name medications.
12don MSN
People have noticed that TrumpRx looks a lot like GoodRx. There’s a reason for the similarities
A new prescription discount website from the federal government is using GoodRx as an integration partner, says the company.
Analysts have nudged their fair value estimate for GoodRx Holdings slightly lower, from about US$4.95 to roughly US$4.56 per share, while also modestly increasing the discount rate from around 9.79% ...
TrumpRx is a website that lists discounted cash prices from pharmaceutical manufacturers. TrumpRx does not sell or dispense drugs. Instead, TrumpRx facilitates consumer access to the selected discount ...
GoodRx reports 2026 will see higher health insurance premiums, Medicare changes, and many opting out of coverage due to increased costs.
Experts say the jury is still out on whether TrumpRx will lead to significant savings on drug prices, though it will likely help people who need medications not commonly covered by insurance.
Under Trump administration deals to lower drug prices, pharmaceutical companies are offering some of their drugs at ...
The Trump administration's new discounted drug platform isn't a game-changer for consumers, health care experts said.
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, today announced it is working with Sanofi (NASDAQ: SNY), a global leader in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results